Fatigue resident survival guide: Difference between revisions
TayyabaAli (talk | contribs) |
No edit summary |
||
(113 intermediate revisions by 5 users not shown) | |||
Line 9: | Line 9: | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC; border-radius: 5px 5px 5px 5px;" align=left | [[{{PAGENAME}}#Causes|Causes]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC; border-radius: 5px 5px 5px 5px;" align=left | [[{{PAGENAME}}#Causes|Causes]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC; border-radius: 5px 5px 5px 5px;" align=left | [[{{PAGENAME}}# | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC; border-radius: 5px 5px 5px 5px;" align=left | [[{{PAGENAME}}#Diagnosis|Diagnosis]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC; border-radius: 5px 5px 5px 5px;" align=left | [[{{PAGENAME}}#Treatment|Treatment]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC; border-radius: 5px 5px 5px 5px;" align=left | [[{{PAGENAME}}#Treatment|Treatment]] | ||
Line 20: | Line 18: | ||
|} | |} | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}}; {{AE}}{{TAM}} | {{CMG}}; {{AE}}{{TAM}}{{MLA}}{{RG}} | ||
{{SK}} | {{SK}}Approach to weakness, Approach to tiredness, Approach to lethargy, Approach to debility | ||
==Overview== | ==Overview== | ||
Fatigue is a common nonspecific symptom due to a wide range of etiologies. Patients often use this term to describe a range of issues such as difficulty initiating activity, decreased capacity to maintain activity, trouble with concentration, memory, and emotional stability; or sleepiness or an uncontrollable need to sleep. The term fatigue can sometimes be used synonymously with tiredness. Fatigue can present alone as a primary symptom or in association with other localizing symptoms. | |||
==Causes== | ==Causes== | ||
Line 42: | Line 40: | ||
** [[Polymyalgia Rheumatica]] | ** [[Polymyalgia Rheumatica]] | ||
** [[Systemic Lupus Erythymatosus]] | ** [[Systemic Lupus Erythymatosus]] | ||
** [[Sjögren's syndrome]] | |||
*[[Inflammatory Bowel Disease]] | |||
* [[Neurologic injury]] | * [[Neurologic injury]] | ||
* [[Adrenal insufficiency]] | *Endocrine Causes: | ||
* [[Thyroid insufficiency]] | ** [[Adrenal insufficiency]] | ||
* [[Hepatic | ** [[Thyroid insufficiency]] | ||
**[[Hyperthyroidism]] | |||
**[[Electrolyte abnormalities]] | |||
* [[Chronic Hepatic diseases]] | |||
* [[Renal insufficiency]] | * [[Renal insufficiency]] | ||
* [[Cardiopulmonary diseases]] | * [[Cardiopulmonary diseases]] | ||
Line 52: | Line 55: | ||
** Peripheral vascular disease | ** Peripheral vascular disease | ||
** Atypical angina | ** Atypical angina | ||
**Obstructive sleep apnea. | |||
* [[Myopathy]] | * [[Myopathy]] | ||
* [[Medications]] | * [[Medications & Substance abuse]] | ||
** Sedative-hypnotics | ** Sedative-hypnotics | ||
** Analgesics | ** Analgesics | ||
Line 61: | Line 65: | ||
** Opioids | ** Opioids | ||
** Antibiotics | ** Antibiotics | ||
**Alcohol | |||
**Marijuana | |||
**Cocaine/other stimulants | |||
** Anticancer agents (like cisplatin and Etoposide) | ** Anticancer agents (like cisplatin and Etoposide) | ||
* Psychological Causes: | * Psychological Causes: | ||
** Depression | ** Depression | ||
Line 71: | Line 77: | ||
*[[Multiple sclerosis]] | *[[Multiple sclerosis]] | ||
*After malignancy treatment, patients can experience different patterns of fatigue from chemotherapy, radiation treatment, or surgery | *After malignancy treatment, patients can experience different patterns of fatigue from chemotherapy, radiation treatment, or surgery. | ||
==Diagnosis== | ==Diagnosis== | ||
The approach to diagnosis of [[fatigue]] is based on a step-wise testing strategy. Below is an algorithm | The approach to the diagnosis of [[fatigue]] is based on a step-wise testing strategy. Below is an algorithm summarizing the identification and laboratory diagnosis of [[fatigue]]. | ||
*Diagnostic evaluation of fatigue when it presents as a predominant symptom includes a detailed history and physical examination, basic laboratory studies, and updated cancer screening interventions. | |||
*Additional diagnostic testing depends on associated localized findings. | |||
*Extensive laboratory studies without a suggestive history or physical exam findings is of limited diagnostic utility while evaluating chronic fatigue. | |||
{{familytree/start |summary=Fatigue.}} | {{familytree/start |summary=Fatigue.}} | ||
{{familytree | | | | | | | | | | | | | A01 | | | A01=<div style="float: left; text-align: left; width: | {{familytree | | | | | | | | | | | | | A01 | | | A01=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Seek proper history, ask patients to describe in their own words, what do they mean by fatigue?''' <br> This will help distinguish [[fatigue]] from <br> ❑ [[somnolence]] <br> ❑ [[muscle weakness]]<br>'''The history should also determine the characteristics, severity, and temporal pattern of fatigue:'''<BR>❑ Onset – Abrupt or gradual, relationship to illness or life event <BR>❑ Course – Stable, improving, or worsening <br>❑ Duration and daily pattern<BR>❑ Factors that alleviate or exacerbate it<BR>❑ Impact on daily life – Ability to work, socialize, participate in family activities<BR>❑ Accommodations that the patient/family has had to make to deal with symptom</div> }} | ||
{{familytree | | | | | | | | | | | | | |!| | | | | | }} | {{familytree | | | | | | | | | | | | | |!| | | | | | }} | ||
{{familytree | | | | | | | | | | | | | | {{familytree | |,|-|-|-|v|-|-|-|v|-|-|-|+|-|-|-|v|-|-|-|v|-|-|-|.| }} | ||
{{familytree | | | | | | | | | | | | | | | {{familytree | |!| | | |!| | | |!| | | |!| | | |!| | | |!| | | |!| | }} | ||
{{familytree | C01 | | C02 | | C03 | | C04 | | C05 | | C06 | | C07 |C01=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Characterize the cardiac symptoms:'''<br> ❑ [[Dyspnea on exertion]] <br>❑ [[Orthopnea]] <br>❑ Leg swelling|C02=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Characterize the pulmonary symptoms:'''<br> ❑ Dyspnea <br>❑ Chronic cough <br>❑ Sputum production <br>❑ Snoring <br>❑ Interrupted breathing during sleep|C03=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Characterize the endocrinologic / metabolic symptoms:'''<br> ❑ [[Hypothyroidism|Cold intolerance]] <br>❑ [[Weight gain]] <br>❑ [[Constipation]] <br>❑ Dry skin <br>❑ [[Hyperthyroidism|Heat intolerance]] <br>❑ [[Weight loss]]<br> ❑ Diarrhea <br> ❑ Moist skin <br>❑ Nausea/vomiting <br>❑ Mental status changes <br>❑ Decreased urine <br>❑ Abdominal distention <br>❑ Gastrointestinal bleeding <br>❑ Salt craving <br>❑ Gastrointestinal complaints <br>❑ Malaise <br>❑ Cognitive dysfunction <br>❑ [[Anorexia]] <br>❑ [[Polydipsia]]/[[polyuria]]|C04=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Characterize the hematologic / neoplastic symptoms:'''<br> ❑ Dizziness <br>❑ Weakness <br>❑ [[Palpitations]] <br>❑ [[Dyspnea]] <br>❑ Weight loss|C05=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Characterize the Infectious diseases symptoms:'''<br> ❑ Fever/chills <br>❑ Sore throat <br>❑ Tender lymph nodes <br>❑ Nausea/vomiting <br>❑ Abdominal discomfort <br>❑ [[Weight loss]] <br>❑ [[Night sweats]] <br>❑ Myalgias|C06=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Characterize the rheumatologic symptoms:'''<br> ❑ Chronic diffuse muscle pain <br>❑ Aching/morning stiffness of shoulders, neck, and hips|C07=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Characterize the psychological symptoms:'''<br>❑ Sad mood <br>❑ [[Anhedonia]] <br>❑ Altered sleep <br>❑ Cognitive dysfunction <br>❑ Generalized nervousness <br>❑ [[Panic attacks]] <br>❑ [[Phobias]] <br>❑ Multiple chronic constitutional and localized complaints</div>}} | |||
{{familytree | |!| | | |!| | | |!| | | |!| | | |!| | | |!| | | |!| | }} | |||
{{familytree | D01 | | D02 | | D03 | | D04 | | D05 | | D06 | | D07 |D01=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Examine the patient:'''<br> ❑ Elevated [[jugular venous distension]] <br>❑ Peripheral edema <br>❑ S3 gallop <br>❑ Inspiratory rales|D02=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Examine the patient:'''<br> ❑ Evidence of hyperinflation <br>❑ [[Wheezing]]<br>❑ [[Rales]]<br>❑ [[Obesity]]<br>❑ Hypertension|D03=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Examine the patient:'''<br> ❑ [[Bradycardia]] <br>❑ [[Goiter]] <br>❑ Slow deep tendon reflex relaxation phase <br>❑ [[Tachycardia]] <br>❑ Ophthalmopathy <br>❑ Hypertension <br>❑ Peripheral edema <br>❑ [[Jaundice]] <br>❑ [[Palmar erythema]] <br>❑ [[Gynecomastia]] <br>❑ [[Splenomegaly]] <br>❑ Evidence of [[ascites]] <br>❑ Hypotension <br>❑ Hyperpigmentation <br>❑ Vitiligo|D04=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Examine the patient:'''<br> ❑ [[Tachycardia]] <br>❑ [[Pallor]]|D05=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Examine the patient:'''<br> ❑ [[Fever]] <br>❑ Exudate pharyngitis <br>❑ Tender cervical adenopathy <br>❑ [[Jaundice]] <br>❑ Tender hepatomegaly <br>❑ New (regurgitant) [[murmur]] <br>❑ [[Cough]] <br>❑ [[Chest pain]] <br>❑ Dyspnea <br>❑ [[Hemoptysis]]|D06=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Examine the patient:'''<br> ❑ Multiple "tender points" on palpation <br>❑ Decreased range of motion of shoulders, neck, and hips|D07=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Examine the patient:'''<br> ❑ Tachycardia<br>❑ Muscle tension</div>}} | |||
{{familytree | |!| | | |!| | | |!| | | |!| | | |!| | | |!| | | |!| | }} | |||
{{familytree | E01 | | E02 | | E03 | | E04 | | E05 | | E06 | | E07 |E01=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Diagnostic work-up:'''<br> ❑ Chest radiograph <br>❑ Echocardiogram|E02=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Diagnostic work-up:'''<br> ❑ Chest radiograph <br>❑ Sleep study|E03=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Diagnostic work-up:'''<br> ❑ [[Thyroid function tests]] <br>❑ [[Renal function tests]]/ serum electrolytes <br>❑ [[Liver function test|Hepatic function tests]] <br>❑ Morning [[cortisol]]/[[ACTH]], [[ACTH stimulation test]] <br>❑Serum [[sodium]] level <br>❑Serum [[calcium]] level|E04=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Diagnostic work-up:'''<br> ❑ [[Complete blood count]]|E05=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Diagnostic work-up:'''<br> ❑ Complete blood/differential count <br>❑ Monospot <br>❑ [[Liver function tests|Hepatic function tests]] <br>❑ Viral hepatitis serologies <br>❑ [[HIV serology]] <br>❑ Blood cultures <br>❑ [[Echocardiogram]] <br>❑ PPD/gamma-interferon assay <br>❑ Chest radiograph|E06=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Diagnostic work-up:'''<br> ❑ [[Erythrocyte sedimentation rate]]|E07=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Diagnostic work-up:'''<br> ❑ Screening tests (eg, PHQ-2, PHQ-9, GAD-7, SSS-8</div>}} | |||
{{familytree | |!| | | |!| | | |!| | | |!| | | |!| | | |!| | | |!| | }} | |||
{{familytree | F01 | | F02 | | F03 | | F04 | | F05 | | F06 | | F07 |F01=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Consider differential diagnosis:'''<br> ❑ | |||
[[Heart failure|Congective heart failure]] <br>❑ [[Atypical angina]] <ref name="pmid17631047">{{cite journal| author=Smith OR, Michielsen HJ, Pelle AJ, Schiffer AA, Winter JB, Denollet J| title=Symptoms of fatigue in chronic heart failure patients: clinical and psychological predictors. | journal=Eur J Heart Fail | year= 2007 | volume= 9 | issue= 9 | pages= 922-7 | pmid=17631047 | doi=10.1016/j.ejheart.2007.05.016 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17631047 }} </ref>|F02=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Consider differential diagnosis:'''<br> ❑ | |||
{{familytree | | | [[Chronic obstructive pulmonary disease]] <ref name="pmid14706002">{{cite journal| author=Theander K, Unosson M| title=Fatigue in patients with chronic obstructive pulmonary disease. | journal=J Adv Nurs | year= 2004 | volume= 45 | issue= 2 | pages= 172-7 | pmid=14706002 | doi=10.1046/j.1365-2648.2003.02878.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14706002 }} </ref> <br>❑ [[Sleep apnea]] <ref name="pmid10720054">{{cite journal| author=Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM | display-authors=etal| title=Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. | journal=J Clin Endocrinol Metab | year= 2000 | volume= 85 | issue= 3 | pages= 1151-8 | pmid=10720054 | doi=10.1210/jcem.85.3.6484 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10720054 }} </ref>|F03=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Consider differential diagnosis:'''<br> ❑ [[Hypothyroidism]] <ref name="pmid22989469">{{cite journal| author=Louwerens M, Appelhof BC, Verloop H, Medici M, Peeters RP, Visser TJ | display-authors=etal| title=Fatigue and fatigue-related symptoms in patients treated for different causes of hypothyroidism. | journal=Eur J Endocrinol | year= 2012 | volume= 167 | issue= 6 | pages= 809-15 | pmid=22989469 | doi=10.1530/EJE-12-0501 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22989469 }} </ref> <br>❑ [[Hyperthyroidism]] <ref name="pmid20656620">{{cite journal| author=Kaltsas G, Vgontzas A, Chrousos G| title=Fatigue, endocrinopathies, and metabolic disorders. | journal=PM R | year= 2010 | volume= 2 | issue= 5 | pages= 393-8 | pmid=20656620 | doi=10.1016/j.pmrj.2010.04.011 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20656620 }} </ref> <br>❑ Inflammatory bowel disease <ref name="pmid32398564">{{cite journal| author=Qazi T| title=Fatigue in inflammatory bowel disease: a problematic ailment. | journal=Curr Opin Gastroenterol | year= 2020 | volume= 36 | issue= 4 | pages= 284-294 | pmid=32398564 | doi=10.1097/MOG.0000000000000644 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32398564 }} </ref><br>❑ [[Chronic renal disease]] <ref name="pmid24335380">{{cite journal| author=Jhamb M, Liang K, Yabes J, Steel JL, Dew MA, Shah N | display-authors=etal| title=Prevalence and correlates of fatigue in chronic kidney disease and end-stage renal disease: are sleep disorders a key to understanding fatigue? | journal=Am J Nephrol | year= 2013 | volume= 38 | issue= 6 | pages= 489-95 | pmid=24335380 | doi=10.1159/000356939 | pmc=3925636 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24335380 }} </ref> <br>❑ [[Chronic hepatic disease]] <ref name="pmid11164055">{{cite journal| author=Dwight MM, Kowdley KV, Russo JE, Ciechanowski PS, Larson AM, Katon WJ| title=Depression, fatigue, and functional disability in patients with chronic hepatitis C. | journal=J Psychosom Res | year= 2000 | volume= 49 | issue= 5 | pages= 311-7 | pmid=11164055 | doi=10.1016/s0022-3999(00)00155-0 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11164055 }} </ref> <br>❑ [[Adrenal insufficiency]] <ref name="pmid30383218">{{cite journal| author=Colombo C, De Leo S, Di Stefano M, Vannucchi G, Persani L, Fugazzola L| title=Primary Adrenal Insufficiency During Lenvatinib or Vandetanib and Improvement of Fatigue After Cortisone Acetate Therapy. | journal=J Clin Endocrinol Metab | year= 2019 | volume= 104 | issue= 3 | pages= 779-784 | pmid=30383218 | doi=10.1210/jc.2018-01836 | pmc=6402317 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30383218 }} </ref> <br>❑ [[Hyponatremia]] <ref name="pmid32595044">{{cite journal| author=| title=Correction to Lancet Infectious Diseases 2020; published online April 29. https://doi.org/10.1016/ S1473-3099(20)30064-5. | journal=Lancet Infect Dis | year= 2020 | volume= 20 | issue= 7 | pages= e148 | pmid=32595044 | doi=10.1016/S1473-3099(20)30370-4 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32595044 }} </ref> <br>❑ [[Hypercalcemia]] <ref name="pmid1705223">{{cite journal |vauthors=McGill KC, Lau K, Dorfman LJ, Westwick CR, Peterson DL, Gleisner JM, Blakley RL |title=A comparison of turns analysis and motor unit analysis in electromyography |journal=Electroencephalogr Clin Neurophysiol |volume=81 |issue=1 |pages=8–17 |date=February 1991 |pmid=1705223 |doi=10.1016/0168-5597(91)90098-i |url=}}</ref>|F04=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Consider differential diagnosis:'''<br> ❑ [[Anemia]] <ref name="pmid1705223">{{cite journal |vauthors=McGill KC, Lau K, Dorfman LJ, Westwick CR, Peterson DL, Gleisner JM, Blakley RL |title=A comparison of turns analysis and motor unit analysis in electromyography |journal=Electroencephalogr Clin Neurophysiol |volume=81 |issue=1 |pages=8–17 |date=February 1991 |pmid=1705223 |doi=10.1016/0168-5597(91)90098-i |url=}}</ref> <br>❑ [[Occult malignancy]] <ref name="pmid10732747">{{cite journal| author=Howell SJ, Radford JA, Smets EM, Shalet SM| title=Fatigue, sexual function and mood following treatment for haematological malignancy: the impact of mild Leydig cell dysfunction. | journal=Br J Cancer | year= 2000 | volume= 82 | issue= 4 | pages= 789-93 | pmid=10732747 | doi=10.1054/bjoc.1999.1000 | pmc=2374403 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10732747 }} </ref>|F05=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Consider differential diagnosis:'''<br> ❑ [[Infectious mononucleosis|Mononucleosis syndrome]] <ref name="pmid19564299">{{cite journal| author=Katz BZ, Shiraishi Y, Mears CJ, Binns HJ, Taylor R| title=Chronic fatigue syndrome after infectious mononucleosis in adolescents. | journal=Pediatrics | year= 2009 | volume= 124 | issue= 1 | pages= 189-93 | pmid=19564299 | doi=10.1542/peds.2008-1879 | pmc=2756827 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19564299 }} </ref> <br>❑ [[Viral hepatitis]] <ref name="pmid12081607">{{cite journal| author=Poynard T, Cacoub P, Ratziu V, Myers RP, Dezailles MH, Mercadier A | display-authors=etal| title=Fatigue in patients with chronic hepatitis C. | journal=J Viral Hepat | year= 2002 | volume= 9 | issue= 4 | pages= 295-303 | pmid=12081607 | doi=10.1046/j.1365-2893.2002.00364.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12081607 }} </ref><br>❑ [[HIV infection]]<ref name="pmid25077353">{{cite journal| author=| title=Retraction notice to “Differential impact of diabetes and hypertension in the brain: adverse effects in grey matter” [Neurobiol. Dis., 44 (2011) 161–173, http://dx.doi.org/10.1016/ j.nbd.2011.06.005]. | journal=Neurobiol Dis | year= 2014 | volume= 68 | issue= | pages= 229 | pmid=25077353 | doi=10.1016/j.nbd.2014.05.006 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25077353 }} </ref> <br>❑ [[Subacute bacterial endocarditis]] <ref name="pmid2829679">{{cite journal| author=Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Schonberger LB, Straus SE | display-authors=etal| title=Chronic fatigue syndrome: a working case definition. | journal=Ann Intern Med | year= 1988 | volume= 108 | issue= 3 | pages= 387-9 | pmid=2829679 | doi=10.7326/0003-4819-108-3-387 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2829679 }} </ref><br>❑ [[Tuberculosis]] <ref name="pmid10">{{cite journal |vauthors=Schmoldt A, Benthe HF, Haberland G, Kahn A, Vives JL, Bertrand O, Cottreau D, Marie J, Boivin P, Flohr H, Breull W, Smith RJ, Bryant RG, Koolman J, Karlson P |title=Digitoxin metabolism by rat liver microsomes |journal=Biochem. Pharmacol. |volume=24 |issue=17 |pages=1639–41 |date=September 1975 |pmid=10 |doi=10.1016/0009-8981(76)90051-6 |url=}}</ref> |F06=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Consider differential diagnosis:'''<br> ❑ [[Fibromyalgia]] <ref name="pmid25996397">{{cite journal| author=| title=Reorganized text. | journal=JAMA Otolaryngol Head Neck Surg | year= 2015 | volume= 141 | issue= 5 | pages= 428 | pmid=25996397 | doi=10.1001/jamaoto.2015.0540 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25996397 }} </ref><br>❑ [[Polymyalgia rheumatica]] <ref name="pmid25366389">{{cite journal| author=Green DJ, Muller S, Mallen CD, Hider SL| title=Fatigue as a precursor to polymyalgia rheumatica: an explorative retrospective cohort study. | journal=Scand J Rheumatol | year= 2015 | volume= 44 | issue= 3 | pages= 219-23 | pmid=25366389 | doi=10.3109/03009742.2014.959047 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25366389 }} </ref><br>❑ [[Rheumatoid arthritis]]<br>❑ [[Sjogren syndrome]]<br>❑ [[Systemic lupus erythematosus]]|F07=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Consider differential diagnosis:'''<br>❑ [[Depression]] <ref name="pmid9540167">{{cite journal| author=Visser MR, Smets EM| title=Fatigue, depression and quality of life in cancer patients: how are they related? | journal=Support Care Cancer | year= 1998 | volume= 6 | issue= 2 | pages= 101-8 | pmid=9540167 | doi=10.1007/s005200050142 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9540167 }} </ref><br>❑ [[Anxiety|Anxiety disorder]] <ref name="pmid9197905">{{cite journal| author=Fischler B, Cluydts R, De Gucht Y, Kaufman L, De Meirleir K| title=Generalized anxiety disorder in chronic fatigue syndrome. | journal=Acta Psychiatr Scand | year= 1997 | volume= 95 | issue= 5 | pages= 405-13 | pmid=9197905 | doi=10.1111/j.1600-0447.1997.tb09653.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9197905 }} </ref><br>❑ [[Somatization disorder]] <ref name="pmid2798731">{{cite journal| author=Manu P, Lane TJ, Matthews DA| title=Somatization disorder in patients with chronic fatigue. | journal=Psychosomatics | year= 1989 | volume= 30 | issue= 4 | pages= 388-95 | pmid=2798731 | doi=10.1016/S0033-3182(89)72244-1 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2798731 }} </ref></div>}} | ||
{{Family tree/end}} | {{Family tree/end}} | ||
==Treatment== | ==Treatment== | ||
. | |||
{{familytree/start |summary=PE diagnosis Algorithm.}} | {{familytree/start |summary=PE diagnosis Algorithm.}} | ||
{{familytree | | | | | | | | A01 |A01= }} | {{familytree | | | | | | | | | | | | | A01 | | | |A01=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Treat the underlying causes''' }} | ||
{{familytree | | | | |,|-|-|-| | {{familytree | | | | | | | | | | | | | |!| | | | | | }} | ||
{{familytree | | | | {{familytree | |,|-|-|-|v|-|-|-|v|-|-|-|+|-|-|-|v|-|-|-|v|-|-|-|.| }} | ||
{{ | {{familytree | |!| | | |!| | | |!| | | |!| | | |!| | | |!| | | |!| | }} | ||
{{ | {{familytree | C01 | | C02 | | C03 | | C04 | | C05 | | C06 | | C07 |C01=<div style="float: left; text-align: left; width: 10em; padding:1em;">''' Fatigue due to [[heart failure]]'''<ref name="pmid20610207">{{cite journal |author=Lindenfeld J, Albert NM, Boehmer JP, Collins SP, Ezekowitz JA, Givertz MM, Katz SD, Klapholz M, Moser DK, Rogers JG, Starling RC, Stevenson WG, Tang WH, Teerlink JR, Walsh MN |title=HFSA 2010 Comprehensive Heart Failure Practice Guideline |journal=[[Journal of Cardiac Failure]] |volume=16 |issue=6 |pages=e1–194 |year=2010 |month=June |pmid=20610207 |doi=10.1016/j.cardfail.2010.04.004 |url=http://linkinghub.elsevier.com/retrieve/pii/S1071-9164(10)00173-9 |accessdate=2013-04-29}}</ref><ref>{{cite journal |author=Gray A, Goodacre S, Newby DE, Masson M, Sampson F, Nicholl J |title=Noninvasive ventilation in acute cardiogenic pulmonary edema |journal=N. Engl. J. Med. |volume=359 |issue=2 |pages=142–51 |year=2008 |month=July |pmid=18614781|doi=10.1056/NEJMoa0707992}}</ref><ref>{{cite journal |author=Peter JV, Moran JL, Phillips-Hughes J, Graham P, Bersten AD |title=Effect of non-invasive positive pressure ventilation (NIPPV) on mortality in patients with acute cardiogenic pulmonary oedema: a meta-analysis |journal=Lancet |volume=367 |issue=9517 |pages=1155–63 |year=2006 |month=April |pmid=16616558|doi=10.1016/S0140-6736(06)68506-1}}</ref><ref>{{cite journal |author=Weng CL |title=Meta-analysis: Noninvasive ventilation in acute cardiogenic pulmonary edema |journal=Ann. Intern. Med. |volume=152 |issue=9 |pages=590–600 |year=2010 |month=May |pmid=20439577 |doi=10.1059/0003-4819-152-9-201005040-00009 |url= |author-separator=, |author2=Zhao YT |author3=Liu QH |display-authors=3 |last4=Fu |first4=CJ |last5=Sun |first5=F |last6=Ma |first6=YL |last7=Chen |first7=YW |last8=He |first8=QY}}</ref> :<br> ❑Diuretics<br> ❑Vasodilator Therapy<br> ❑Inotropic Therapy<br> ❑Vasopressor Support<br> ❑ACE Inhibition<br> ❑Beta Blockers<br> ❑Aldosterone Antagonism<br> ❑Morphine<br>'''Fatigue due to [[stable angina]]<ref name="pmid16391169">Smith SC, Feldman TE, Hirshfeld JW, Jacobs AK, Kern MJ, King SB et al. (2006) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=16391169 ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention).] ''Circulation'' 113 (1):156-75. [http://dx.doi.org/10.1161/CIRCULATIONAHA.105.170815 DOI:10.1161/CIRCULATIONAHA.105.170815] PMID: [http://pubmed.gov/16391169 16391169]</ref>''': <br> ❑Antiplatelet agents<br> ❑Antianginal agents<br> ❑ACEI/RAAS Blockers|C02=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Ftigue due to [[Chronic obstructive pulmonary disease]]<ref name="pmid20075385">{{cite journal |author=Rice KL, Dewan N, Bloomfield HE, Grill J, Schult TM, Nelson DB, Kumari S, Thomas M, Geist LJ, Beaner C, Caldwell M, Niewoehner DE |title=Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial |journal=[[American Journal of Respiratory and Critical Care Medicine]] |volume=182 |issue=7 |pages=890–6 |year=2010 |month=October |pmid=20075385 |doi=10.1164/rccm.200910-1579OC |url=http://ajrccm.atsjournals.org/cgi/pmidlookup?view=long&pmid=20075385 |accessdate=2012-03-20}}</ref><ref name="pmid21513435">{{cite journal |author=Dewan NA, Rice KL, Caldwell M, Hilleman DE |title=Economic evaluation of a disease management program for chronic obstructive pulmonary disease |journal=[[Copd]] |volume=8 |issue=3 |pages=153–9 |year=2011 |month=June |pmid=21513435 |doi=10.3109/15412555.2011.560129 |url=http://informahealthcare.com/doi/abs/10.3109/15412555.2011.560129 |accessdate=2012-03-20}}</ref><ref name="pmid21349928">{{cite journal |author=Chapman KR, Rennard SI, Dogra A, Owen R, Lassen C, Kramer B |title=Long-term safety and efficacy of indacaterol, a long-acting β₂-agonist, in subjects with COPD: a randomized, placebo-controlled study |journal=[[Chest]] |volume=140 |issue=1 |pages=68–75 |year=2011 |month=July |pmid=21349928 |doi=10.1378/chest.10-1830 |url=http://www.chestjournal.org/cgi/pmidlookup?view=long&pmid=21349928 |accessdate=2012-03-19}}</ref>.''':<br> ❑Beta Adrenergic Receptor Agonists<br> ❑Long Acting Beta-2 Adrenergic Receptor Agonist<br> ❑Anticholinergics<br> ❑Phosphodiesterase Inhibitor<br> ❑Steroid <br> ❑Antibiotics <br> ❑Mucolytic<br>'''Fatigue due to [[sleep apnea]]:'''<ref name="pmid22618923">{{cite journal |author=Barbé F, Durán-Cantolla J, Sánchez-de-la-Torre M, ''et al.'' |title=Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial |journal=JAMA |volume=307 |issue=20 |pages=2161–8 |year=2012 |month=May |pmid=22618923 |doi=10.1001/jama.2012.4366 |url=http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2012.4366}}</ref>.<ref>Martínez-García M, Capote F, Campos-Rodríguez F, et al. Effect of CPAP on Blood Pressure in Patients With Obstructive Sleep Apnea and Resistant Hypertension: The HIPARCO Randomized Clinical Trial. JAMA. 2013;310(22):2407-2415. {{doi|10.1001/jama.2013.281250}}.</ref><ref name="pmid23598607">{{cite journal| author=Pedrosa RP, Drager LF, de Paula LK, Amaro AC, Bortolotto LA, Lorenzi-Filho G| title=Effects of OSA Treatment on BP in Patients With Resistant Hypertension: A Randomized Trial. | journal=Chest | year= 2013 | volume= 144 | issue= 5 |pages= 1487-94 | pmid=23598607 | doi=10.1378/chest.13-0085 | pmc= |url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23598607 }} </ref><ref name="pmid19959590">{{cite journal| author=Johansson K, Neovius M, Lagerros YT, Harlid R, Rössner S, Granath F et al.| title=Effect of a very low energy diet on moderate and severe obstructive sleep apnoea in obese men: a randomised controlled trial. | journal=BMJ | year= 2009 | volume= 339 | issue= | pages= b4609 |pmid=19959590 | ||
{{ | | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&email=badgett@uthscdsa.edu&retmode=ref&cmd=prlinks&id=19959590 | pmc=PMC2788899| doi=10.1136/bmj.b4609 }} <!--Formatted by http://sumsearch.uthscsa.edu/cite/--></ref><ref name='Hsu2003'>{{Cite journal|author=Hsu AA, Lo C |title=Continuous positive airway pressure therapy in sleep apnoea |journal=Respirology |volume=8 |issue=4 |pages=447–54 |year=2003 |month=December |pmid=14708553 |doi=10.1046/j.1440-1843.2003.00494.x}}</ref><br> ❑Weight loss<br> ❑Continuous positive airway pressure<br> ❑Oral appliances<br> ❑Modafinil 200-400 mg per day<br> ❑Acetazolamide|C03=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Fatigue due to [[hypothyroidism]]:'''.<ref name="pmid19949140">{{cite journal |vauthors=McDermott MT |title=In the clinic. Hypothyroidism |journal=Ann. Intern. Med. |volume=151 |issue=11 |pages=ITC61 |year=2009 |pmid=19949140 |doi=10.7326/0003-4819-151-11-200912010-01006 |url=}}</ref><ref name="pmid11836274">{{cite journal |vauthors=Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE |title=Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III) |journal=J. Clin. Endocrinol. Metab. |volume=87 |issue=2 |pages=489–99 |year=2002 |pmid=11836274 |doi=10.1210/jcem.87.2.8182 |url=}}</ref><br><ref name="pmid18177256">{{cite journal |vauthors=Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR |title=Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002) |journal=Thyroid |volume=17 |issue=12 |pages=1211–23 |year=2007 |pmid=18177256 |doi=10.1089/thy.2006.0235 |url=}}</ref>:<br> ❑Synthetic T4(Levothyroxin)<br>'''Fatigue due to [[hyperthyroidism]]:'''<ref name="pmid14262190">{{cite journal |vauthors=ADAMS DD |title=PATHOGENESIS OF THE HYPERTHYROIDISM OF GRAVES'S DISEASE |journal=Br Med J |volume=1 |issue=5441 |pages=1015–9 |year=1965 |pmid=14262190 |pmc=2166943 |doi= |url=}}</ref><br> ❑Beta blockers<br> ❑Methimazole<br> ❑Propylthiouracil<br>'''Fatigue due to [[Chronic Renal Failure]]:<ref name="pmid16935995">{{cite journal| author=Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al.| title=ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. | journal=Circulation | year= 2006 | volume= 114 | issue= 10 | pages= e385-484 | pmid=16935995 | doi=10.1161/CIRCULATIONAHA.106.178233 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16935995}}</ref>'''<br> ❑Blood pressure management<br> ❑Kidney Transplant<br> |C04=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Fatigue due to [[anemia]]''':<ref name="pmid14707558">{{cite journal |author=Corwin HL, Gettinger A, Pearl RG, ''et al'' |title=The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States |journal=Crit. Care Med. |volume=32 |issue=1 |pages=39–52 |year=2004 |pmid=14707558 |doi=10.1097/01.CCM.0000104112.34142.79}}</ref><ref name="pmid12243637">{{cite journal |author=Vincent JL, Baron JF, Reinhart K, ''et al'' |title=Anemia and blood transfusion in critically ill patients |journal=JAMA |volume=288 |issue=12 |pages=1499–507 |year=2002 |pmid=12243637 |doi=}}</ref> | ||
{{ | <ref>MEDICAL SCIENCES | ||
{{ | S-nitrosohemoglobin deficiency: A mechanism for loss of physiological activity in banked blood | ||
{{ | James D. Reynolds*, Gregory S. Ahearn{dagger}, Michael Angelo{dagger}, Jian Zhang{dagger}, Fred Cobb{dagger},{ddagger}, and Jonathan S. Stamler Published online before print October 11, 2007 | ||
{{ | Proc. Natl. Acad. Sci. USA, 10.1073/pnas.0707958104 Accessed 10/15/07</ref><br> ❑Blood transfusion,<br> ❑Iron transfusion<br> ❑Folate therapy<br> ❑Vit B12|C05=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Fatigue due to [[Mononucleosis]]'''<ref>{{cite journal | author=Candy B, Hotopf M. | year=2006 | issue=4 | pages=CD004402 | journal=Cochrane Database Sys Rev | title=Steroids for symptom control in infectious mononucleosis | pmid=16856045 | doi=10.1002/14651858.CD004402.pub2 }}</ref><br><ref name="TGAntibiotic13">Antibiotic Expert Group. Therapeutic guidelines: Antibiotic. 13th ed. North Melbourne: Therapeutic Guidelines; 2006.</ref><ref name="WebMD">{{cite web |title=Infectious Mononucleosis |url=http://www.webmd.com/hw/infection/hw168622.asp |date= Jan 24, 2006 |publisher=WebMD |accessdate=2006-07-10}}</ref><ref name="Torre1999">{{cite journal |author=Torre D, Tambini R |title=Acyclovir for treatment of infectious mononucleosis: a meta-analysis |journal=Scand. J. Infect. Dis. |volume=31 |issue=6 |pages=543–7 |year=1999 |pmid=10680982 |doi=}}</ref><ref name="pmid17369082">{{cite journal |author=Balfour HH, Hokanson KM, Schacherer RM, ''et al'' |title=A virologic pilot study of valacyclovir in infectious mononucleosis |journal=J. Clin. Virol. |volume=39 |issue=1 |pages=16–21 |year=2007 |pmid=17369082 |doi=10.1016/j.jcv.2007.02.002}}</ref><ref>{{cite journal |author=Simon et al. |title=The Effect of Valacyclovir and Prednisolone in Reducing Symptoms of EBV Illness In Children: A Double-Blind, Placebo-Controlled Study. |journal=International Pediatrics |volume=18 |issue=3 |pages=164-169 |year=2003 |month=March}}</ref><ref>{{cite journal |author=Balfour HH, Hokanson KM, Schacherer RM, ''et al'' |title=A virologic pilot study of valacyclovir in infectious mononucleosis |journal=J. Clin. Virol. |volume=39 |issue=1 |pages=16–21 |year=2007 |pmid=17369082 |doi=10.1016/j.jcv.2007.02.002}}</ref> <br> ❑[[NSAID]]<br> ❑Intravenous corticostreoid<br> ❑[[Acyclovir]]<br> ❑Opioid analgesics <br>'''Fatigue due to [[Viral Hepatitis]]'''.<ref name="pmid11799479">{{cite journal| author=Vargas HE, Dodson FS, Rakela J| title=A concise update on the status of liver transplantation for hepatitis B virus: the challenges in 2002. | journal=Liver Transpl | year= 2002 | volume= 8 | issue= 1 | pages= 2-9 | pmid=11799479 | doi=10.1053/jlts.2002.29765 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11799479 }} </ref><ref name="pmid2202639">{{cite journal| author=Omata M| title=Significance of extrahepatic replication of hepatitis B virus. | journal=Hepatology | year= 1990 | volume= 12 | issue= 2 | pages= 364-6 | pmid=2202639 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2202639 }} </ref><ref name="pmid8629297">{{cite journal| author=McGory RW, Ishitani MB, Oliveira WM, Stevenson WC, McCullough CS, Dickson RC et al.| title=Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. | journal=Transplantation | year= 1996 | volume= 61 | issue= 9 | pages= 1358-64 | pmid=8629297 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8629297 }} </ref><ref name="pmid15776431">{{cite journal| author=Marzano A, Gaia S, Ghisetti V, Carenzi S, Premoli A, Debernardi-Venon W et al.| title=Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence. | journal=Liver Transpl | year= 2005 | volume= 11 | issue= 4 | pages= 402-9 | pmid=15776431 | doi=10.1002/lt.20402 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15776431 }} </ref>:<br> ❑Entecavir<br> ❑Tenofovir<br> ❑Interferon-α 2b<br> ❑PegIFNα<br> ❑Telbivudine<br> ❑Adefovir<br> ❑Lamivudine<br>'''Fatigue due to [[Endocarditis]]'''<ref name="pmid24603192">{{cite journal |vauthors=Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA, O'Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM, Thomas JD |title=2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines |journal=J. Am. Coll. Cardiol. |volume=63 |issue=22 |pages=2438–88 |year=2014 |pmid=24603192 |doi=10.1016/j.jacc.2014.02.537 |url=}}</ref>:<br> ❑Empiric antibiotics<br> ❑Antithrombotic therapy|C06=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Fatigue due to [[Fibromyalgia]]''':<ref name="pmid14661675">{{cite journal|author=Plotnikoff GA, Quigley JM |title=Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain |journal=Mayo Clin. Proc.|volume=78 |issue=12 |pages=1463–70 |year=2003 |pmid=14661675 |doi=}}</ref>; <ref name="pmid18431091">{{cite journal|author=Warner AE, Arnspiger SA |title=Diffuse musculoskeletal pain is not associated with low vitamin D levels or improved by treatment with vitamin D |journal=J Clin Rheumatol |volume=14 |issue=1 |pages=12–6 |year=2008 |month=February |pmid=18431091 |doi=10.1097/RHU.0b013e31816356a9 |url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00124743-200802000-00003 |issn=}}</ref><ref name="pmid19364687">{{cite journal| author=Arvold DS, Odean MJ, Dornfeld MP, Regal RR, Arvold JG, Karwoski GC et al.| title=Correlation of symptoms with vitamin D deficiency and symptom response to cholecalciferol treatment: a randomized controlled trial. | journal=Endocr Pract | year= 2009 | volume= 15 | issue= 3 | pages= 203-12 | pmid=19364687 | doi= | pmc= |url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19364687 }} </ref><br> ❑Amitriptiline<br> ❑Cyclobenzaprine<br> ❑Dulexitine<br> ❑Minlacipran<br> ❑Pregabalin<br>'''Fatigue due to [[Polymyalgia]]''':<ref name="pmid23051717">{{cite journal| author=Kermani TA, Warrington KJ| title=Polymyalgia rheumatica. | journal=Lancet | year= 2013 | volume= 381 | issue= 9860 | pages= 63-72 | pmid=23051717 | doi=10.1016/S0140-6736(12)60680-1 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23051717 }} </ref><ref name="pmid23051717">{{cite journal| author=Kermani TA, Warrington KJ| title=Polymyalgia rheumatica. | journal=Lancet | year= 2013 | volume= 381 | issue= 9860 | pages= 63-72 | pmid=23051717 | doi=10.1016/S0140-6736(12)60680-1 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23051717 }} </ref><br> ❑Glucocorticosteroids<br>'''Fatigue due to [[Rheumatoid arthritis]]:<ref name="pmid29129326">{{cite journal |vauthors=Xu C, Peng H, Li R, Chai W, Li X, Fu J, Liu K, Yu B, Jia C, Chen J |title=Risk factors and clinical characteristics of deep knee infection in patients with intra-articular injections: A matched retrospective cohort analysis |journal=Semin. Arthritis Rheum. |volume= |issue= |pages= |date=October 2017 |pmid=29129326 |doi=10.1016/j.semarthrit.2017.10.013 |url=}}</ref><ref name="pmid16258899">{{cite journal |vauthors=Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, Zwinderman AH, Ronday HK, Han KH, Westedt ML, Gerards AH, van Groenendael JH, Lems WF, van Krugten MV, Breedveld FC, Dijkmans BA |title=Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial |journal=Arthritis Rheum. |volume=52 |issue=11 |pages=3381–90 |date=November 2005 |pmid=16258899 |doi=10.1002/art.21405 |url=}}</ref><br><ref name="pmid18662933">{{cite journal |vauthors=van der Kooij SM, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Güler-Yüksel M, Zwinderman AH, Kerstens PJ, van der Lubbe PA, de Beus WM, Grillet BA, Ronday HK, Huizinga TW, Breedveld FC, Dijkmans BA, Allaart CF |title=Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis |journal=Ann. Rheum. Dis. |volume=68 |issue=6 |pages=914–21 |date=June 2009 |pmid=18662933 |doi=10.1136/ard.2008.092254 |url=}}</ref>'''<br> ❑Leflunomide<br> ❑Sulfasalazine<br> ❑Hydroxycloroquine<br> ❑Rituximab<br> ❑Tocolizumab<br> ❑Azathioprim<br> ❑Cyclosporine<br> ❑Anakirna<br> ❑Abatacept<br> ❑Baricitinib<br> ❑DMARDS<br>'''Fatigue due to [[Sjögren's syndrome]]<ref name="pmid18984418">{{cite journal |vauthors=Wu AJ |title=Optimizing dry mouth treatment for individuals with Sjögren's syndrome |journal=Rheum. Dis. Clin. North Am. |volume=34 |issue=4 |pages=1001–10, x |date=November 2008 |pmid=18984418 |doi=10.1016/j.rdc.2008.08.013 |url=}}</ref><ref name="pmid17714766">{{cite journal |vauthors=Thanou-Stavraki A, James JA |title=Primary Sjogren's syndrome: current and prospective therapies |journal=Semin. Arthritis Rheum. |volume=37 |issue=5 |pages=273–92 |date=April 2008 |pmid=17714766 |doi=10.1016/j.semarthrit.2007.06.002 |url=}}</ref><ref name="pmid22549247">{{cite journal |vauthors=Ramos-Casals M, Brito-Zerón P, Sisó-Almirall A, Bosch X, Tzioufas AG |title=Topical and systemic medications for the treatment of primary Sjögren's syndrome |journal=Nat Rev Rheumatol |volume=8 |issue=7 |pages=399–411 |date=May 2012 |pmid=22549247 |doi=10.1038/nrrheum.2012.53 |url=}}</ref><br><ref name="pmid22161442">{{cite journal |vauthors=Furness S, Worthington HV, Bryan G, Birchenough S, McMillan R |title=Interventions for the management of dry mouth: topical therapies |journal=Cochrane Database Syst Rev |volume= |issue=12 |pages=CD008934 |date=December 2011 |pmid=22161442 |doi=10.1002/14651858.CD008934.pub2 |url=}}</ref>'''<br> ❑Pilocarpine<br> ❑Cevimeline<br> ❑Methotroxate|C07=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''Fatigue due to [[Mood disorders]]:<ref name="DSMV">{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref>'''<br> ❑CBT<br> ❑Anti depresant therapy<br> ❑Anxiolytic therapy }} | ||
{{ | |||
{{familytree/end}} | {{familytree/end}} | ||
==Do's== | ==Do's== | ||
* | *Though most of the conditions presenting with fatigue have the luxury of time for appropriate evaluation & treatment, a few may require immediate diagnosis & treatment to prevent death or serious sequelae. | ||
*In case of Cardiovascular emergencies: In symptomatic Heart failure secondary to atrial fibrillation, hemodynamically unstable patients require urgent direct-current cardioversion. | |||
*Endocrine disorders: Diabetic ketoacidosis or nonketotic hyperglycemic states require urgent correction of blood sugar levels, acidosis, electrolyte & Fluid imbalances. | |||
*Infectious disease | |||
**Untreated tuberculosis: respiratory failure and systemic spread of disease in immunocompromised individuals. | |||
**HIV, if not diagnosed or treated appropriately with antiretroviral drugs, may result in overt AIDS and eventually death. | |||
**Coronavirus disease 2019 (COVID-19) | |||
***Patients may develop severe viral pneumonia leading to acute respiratory distress syndrome that is potentially fatal. | |||
***Suspected COVID-19 infection should be isolated from others, along with contact and droplet precautions, airborne precautions if performing aerosol-generating procedures. | |||
==Don'ts== | ==Don'ts== | ||
* | *Extensive laboratory work-up is rarely helpful in the absence of suggestive signs and symptoms. | ||
*Mannitol is contraindicated in fatigue treatment. | |||
==References== | ==References== | ||
Line 136: | Line 143: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
{{reflist|2}} | {{reflist|2}} | ||
<references /> | |||
[[Category:Up-To-Date]] | |||
[[Category: |
Latest revision as of 18:57, 24 September 2020
Fatigue Resident Survival Guide |
---|
Overview |
Causes |
Diagnosis |
Treatment |
Do's |
Don'ts |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Tayyaba Ali, M.D.[2]Mounika Lakhmalla, MBBS[3]Ramyar Ghandriz MD[4]
Synonyms and keywords:Approach to weakness, Approach to tiredness, Approach to lethargy, Approach to debility
Overview
Fatigue is a common nonspecific symptom due to a wide range of etiologies. Patients often use this term to describe a range of issues such as difficulty initiating activity, decreased capacity to maintain activity, trouble with concentration, memory, and emotional stability; or sleepiness or an uncontrollable need to sleep. The term fatigue can sometimes be used synonymously with tiredness. Fatigue can present alone as a primary symptom or in association with other localizing symptoms.
Causes
Life Threatening Causes
Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated.
Common Causes
- Infection
- Diabetes
- Hypercalcemia
- Anemia
- Rheumatologic diseases
- Inflammatory Bowel Disease
- Neurologic injury
- Endocrine Causes:
- Chronic Hepatic diseases
- Renal insufficiency
- Cardiopulmonary diseases
- Congestive heart failure
- Chronic obstructive pulmonary disease
- Peripheral vascular disease
- Atypical angina
- Obstructive sleep apnea.
- Myopathy
- Medications & Substance abuse
- Sedative-hypnotics
- Analgesics
- Antihypertensives
- Antidepressants
- Muscle relaxants
- Opioids
- Antibiotics
- Alcohol
- Marijuana
- Cocaine/other stimulants
- Anticancer agents (like cisplatin and Etoposide)
- Psychological Causes:
- Depression
- Anxiety
- Somatization disorder
- Dysthymic disorder
- chronic fatigue syndrome
- Multiple sclerosis
- After malignancy treatment, patients can experience different patterns of fatigue from chemotherapy, radiation treatment, or surgery.
Diagnosis
The approach to the diagnosis of fatigue is based on a step-wise testing strategy. Below is an algorithm summarizing the identification and laboratory diagnosis of fatigue.
- Diagnostic evaluation of fatigue when it presents as a predominant symptom includes a detailed history and physical examination, basic laboratory studies, and updated cancer screening interventions.
- Additional diagnostic testing depends on associated localized findings.
- Extensive laboratory studies without a suggestive history or physical exam findings is of limited diagnostic utility while evaluating chronic fatigue.
Seek proper history, ask patients to describe in their own words, what do they mean by fatigue? This will help distinguish fatigue from ❑ somnolence ❑ muscle weakness The history should also determine the characteristics, severity, and temporal pattern of fatigue: ❑ Onset – Abrupt or gradual, relationship to illness or life event ❑ Course – Stable, improving, or worsening ❑ Duration and daily pattern ❑ Factors that alleviate or exacerbate it ❑ Impact on daily life – Ability to work, socialize, participate in family activities ❑ Accommodations that the patient/family has had to make to deal with symptom | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Characterize the pulmonary symptoms: ❑ Dyspnea ❑ Chronic cough ❑ Sputum production ❑ Snoring ❑ Interrupted breathing during sleep | Characterize the endocrinologic / metabolic symptoms: ❑ Cold intolerance ❑ Weight gain ❑ Constipation ❑ Dry skin ❑ Heat intolerance ❑ Weight loss ❑ Diarrhea ❑ Moist skin ❑ Nausea/vomiting ❑ Mental status changes ❑ Decreased urine ❑ Abdominal distention ❑ Gastrointestinal bleeding ❑ Salt craving ❑ Gastrointestinal complaints ❑ Malaise ❑ Cognitive dysfunction ❑ Anorexia ❑ Polydipsia/polyuria | Characterize the hematologic / neoplastic symptoms: ❑ Dizziness ❑ Weakness ❑ Palpitations ❑ Dyspnea ❑ Weight loss | Characterize the Infectious diseases symptoms: ❑ Fever/chills ❑ Sore throat ❑ Tender lymph nodes ❑ Nausea/vomiting ❑ Abdominal discomfort ❑ Weight loss ❑ Night sweats ❑ Myalgias | Characterize the rheumatologic symptoms: ❑ Chronic diffuse muscle pain ❑ Aching/morning stiffness of shoulders, neck, and hips | Characterize the psychological symptoms: ❑ Sad mood ❑ Anhedonia ❑ Altered sleep ❑ Cognitive dysfunction ❑ Generalized nervousness ❑ Panic attacks ❑ Phobias ❑ Multiple chronic constitutional and localized complaints | ||||||||||||||||||||||||||||||||||||||||||||||||||
Examine the patient: ❑ Elevated jugular venous distension ❑ Peripheral edema ❑ S3 gallop ❑ Inspiratory rales | Examine the patient: ❑ Bradycardia ❑ Goiter ❑ Slow deep tendon reflex relaxation phase ❑ Tachycardia ❑ Ophthalmopathy ❑ Hypertension ❑ Peripheral edema ❑ Jaundice ❑ Palmar erythema ❑ Gynecomastia ❑ Splenomegaly ❑ Evidence of ascites ❑ Hypotension ❑ Hyperpigmentation ❑ Vitiligo | Examine the patient: ❑ Fever ❑ Exudate pharyngitis ❑ Tender cervical adenopathy ❑ Jaundice ❑ Tender hepatomegaly ❑ New (regurgitant) murmur ❑ Cough ❑ Chest pain ❑ Dyspnea ❑ Hemoptysis | Examine the patient: ❑ Multiple "tender points" on palpation ❑ Decreased range of motion of shoulders, neck, and hips | Examine the patient: ❑ Tachycardia ❑ Muscle tension | |||||||||||||||||||||||||||||||||||||||||||||||||||
Diagnostic work-up: ❑ Chest radiograph ❑ Echocardiogram | Diagnostic work-up: ❑ Chest radiograph ❑ Sleep study | Diagnostic work-up: ❑ Thyroid function tests ❑ Renal function tests/ serum electrolytes ❑ Hepatic function tests ❑ Morning cortisol/ACTH, ACTH stimulation test ❑Serum sodium level ❑Serum calcium level | Diagnostic work-up: ❑ Complete blood count | Diagnostic work-up: ❑ Complete blood/differential count ❑ Monospot ❑ Hepatic function tests ❑ Viral hepatitis serologies ❑ HIV serology ❑ Blood cultures ❑ Echocardiogram ❑ PPD/gamma-interferon assay ❑ Chest radiograph | Diagnostic work-up: ❑ Erythrocyte sedimentation rate | Diagnostic work-up: ❑ Screening tests (eg, PHQ-2, PHQ-9, GAD-7, SSS-8 | |||||||||||||||||||||||||||||||||||||||||||||||||
Consider differential diagnosis: ❑ Hypothyroidism [4] ❑ Hyperthyroidism [5] ❑ Inflammatory bowel disease [6] ❑ Chronic renal disease [7] ❑ Chronic hepatic disease [8] ❑ Adrenal insufficiency [9] ❑ Hyponatremia [10] ❑ Hypercalcemia [11] | Consider differential diagnosis: ❑ Mononucleosis syndrome [13] ❑ Viral hepatitis [14] ❑ HIV infection[15] ❑ Subacute bacterial endocarditis [16] ❑ Tuberculosis [17] | Consider differential diagnosis: ❑ Fibromyalgia [18] ❑ Polymyalgia rheumatica [19] ❑ Rheumatoid arthritis ❑ Sjogren syndrome ❑ Systemic lupus erythematosus | Consider differential diagnosis: ❑ Depression [20] ❑ Anxiety disorder [21] ❑ Somatization disorder [22] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Treatment
.
Treat the underlying causes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fatigue due to heart failure[23][24][25][26] : ❑Diuretics ❑Vasodilator Therapy ❑Inotropic Therapy ❑Vasopressor Support ❑ACE Inhibition ❑Beta Blockers ❑Aldosterone Antagonism ❑Morphine Fatigue due to stable angina[27]: ❑Antiplatelet agents ❑Antianginal agents ❑ACEI/RAAS Blockers | Ftigue due to Chronic obstructive pulmonary disease[28][29][30].: ❑Beta Adrenergic Receptor Agonists ❑Long Acting Beta-2 Adrenergic Receptor Agonist ❑Anticholinergics ❑Phosphodiesterase Inhibitor ❑Steroid ❑Antibiotics ❑Mucolytic Fatigue due to sleep apnea:[31].[32][33][34][35] ❑Weight loss ❑Continuous positive airway pressure ❑Oral appliances ❑Modafinil 200-400 mg per day ❑Acetazolamide | Fatigue due to hypothyroidism:.[36][37] [38]: ❑Synthetic T4(Levothyroxin) Fatigue due to hyperthyroidism:[39] ❑Beta blockers ❑Methimazole ❑Propylthiouracil Fatigue due to Chronic Renal Failure:[40] ❑Blood pressure management ❑Kidney Transplant | Fatigue due to Mononucleosis[44] [45][46][47][48][49][50] ❑NSAID ❑Intravenous corticostreoid ❑Acyclovir ❑Opioid analgesics Fatigue due to Viral Hepatitis.[51][52][53][54]: ❑Entecavir ❑Tenofovir ❑Interferon-α 2b ❑PegIFNα ❑Telbivudine ❑Adefovir ❑Lamivudine Fatigue due to Endocarditis[55]: ❑Empiric antibiotics ❑Antithrombotic therapy | Fatigue due to Fibromyalgia:[56]; [57][58] ❑Amitriptiline ❑Cyclobenzaprine ❑Dulexitine ❑Minlacipran ❑Pregabalin Fatigue due to Polymyalgia:[59][59] ❑Glucocorticosteroids Fatigue due to Rheumatoid arthritis:[60][61] [62] ❑Leflunomide ❑Sulfasalazine ❑Hydroxycloroquine ❑Rituximab ❑Tocolizumab ❑Azathioprim ❑Cyclosporine ❑Anakirna ❑Abatacept ❑Baricitinib ❑DMARDS Fatigue due to Sjögren's syndrome[63][64][65] [66] ❑Pilocarpine ❑Cevimeline ❑Methotroxate | |||||||||||||||||||||||||||||||||||||||||||||||||||
Do's
- Though most of the conditions presenting with fatigue have the luxury of time for appropriate evaluation & treatment, a few may require immediate diagnosis & treatment to prevent death or serious sequelae.
- In case of Cardiovascular emergencies: In symptomatic Heart failure secondary to atrial fibrillation, hemodynamically unstable patients require urgent direct-current cardioversion.
- Endocrine disorders: Diabetic ketoacidosis or nonketotic hyperglycemic states require urgent correction of blood sugar levels, acidosis, electrolyte & Fluid imbalances.
- Infectious disease
- Untreated tuberculosis: respiratory failure and systemic spread of disease in immunocompromised individuals.
- HIV, if not diagnosed or treated appropriately with antiretroviral drugs, may result in overt AIDS and eventually death.
- Coronavirus disease 2019 (COVID-19)
- Patients may develop severe viral pneumonia leading to acute respiratory distress syndrome that is potentially fatal.
- Suspected COVID-19 infection should be isolated from others, along with contact and droplet precautions, airborne precautions if performing aerosol-generating procedures.
Don'ts
- Extensive laboratory work-up is rarely helpful in the absence of suggestive signs and symptoms.
- Mannitol is contraindicated in fatigue treatment.
References
- ↑ Smith OR, Michielsen HJ, Pelle AJ, Schiffer AA, Winter JB, Denollet J (2007). "Symptoms of fatigue in chronic heart failure patients: clinical and psychological predictors". Eur J Heart Fail. 9 (9): 922–7. doi:10.1016/j.ejheart.2007.05.016. PMID 17631047.
- ↑ Theander K, Unosson M (2004). "Fatigue in patients with chronic obstructive pulmonary disease". J Adv Nurs. 45 (2): 172–7. doi:10.1046/j.1365-2648.2003.02878.x. PMID 14706002.
- ↑ Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM; et al. (2000). "Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia". J Clin Endocrinol Metab. 85 (3): 1151–8. doi:10.1210/jcem.85.3.6484. PMID 10720054.
- ↑ Louwerens M, Appelhof BC, Verloop H, Medici M, Peeters RP, Visser TJ; et al. (2012). "Fatigue and fatigue-related symptoms in patients treated for different causes of hypothyroidism". Eur J Endocrinol. 167 (6): 809–15. doi:10.1530/EJE-12-0501. PMID 22989469.
- ↑ Kaltsas G, Vgontzas A, Chrousos G (2010). "Fatigue, endocrinopathies, and metabolic disorders". PM R. 2 (5): 393–8. doi:10.1016/j.pmrj.2010.04.011. PMID 20656620.
- ↑ Qazi T (2020). "Fatigue in inflammatory bowel disease: a problematic ailment". Curr Opin Gastroenterol. 36 (4): 284–294. doi:10.1097/MOG.0000000000000644. PMID 32398564 Check
|pmid=
value (help). - ↑ Jhamb M, Liang K, Yabes J, Steel JL, Dew MA, Shah N; et al. (2013). "Prevalence and correlates of fatigue in chronic kidney disease and end-stage renal disease: are sleep disorders a key to understanding fatigue?". Am J Nephrol. 38 (6): 489–95. doi:10.1159/000356939. PMC 3925636. PMID 24335380.
- ↑ Dwight MM, Kowdley KV, Russo JE, Ciechanowski PS, Larson AM, Katon WJ (2000). "Depression, fatigue, and functional disability in patients with chronic hepatitis C." J Psychosom Res. 49 (5): 311–7. doi:10.1016/s0022-3999(00)00155-0. PMID 11164055.
- ↑ Colombo C, De Leo S, Di Stefano M, Vannucchi G, Persani L, Fugazzola L (2019). "Primary Adrenal Insufficiency During Lenvatinib or Vandetanib and Improvement of Fatigue After Cortisone Acetate Therapy". J Clin Endocrinol Metab. 104 (3): 779–784. doi:10.1210/jc.2018-01836. PMC 6402317. PMID 30383218.
- ↑ "Correction to Lancet Infectious Diseases 2020; published online April 29. https://doi.org/10.1016/ S1473-3099(20)30064-5". Lancet Infect Dis. 20 (7): e148. 2020. doi:10.1016/S1473-3099(20)30370-4. PMID 32595044 Check
|pmid=
value (help). External link in|title=
(help) - ↑ 11.0 11.1 McGill KC, Lau K, Dorfman LJ, Westwick CR, Peterson DL, Gleisner JM, Blakley RL (February 1991). "A comparison of turns analysis and motor unit analysis in electromyography". Electroencephalogr Clin Neurophysiol. 81 (1): 8–17. doi:10.1016/0168-5597(91)90098-i. PMID 1705223.
- ↑ Howell SJ, Radford JA, Smets EM, Shalet SM (2000). "Fatigue, sexual function and mood following treatment for haematological malignancy: the impact of mild Leydig cell dysfunction". Br J Cancer. 82 (4): 789–93. doi:10.1054/bjoc.1999.1000. PMC 2374403. PMID 10732747.
- ↑ Katz BZ, Shiraishi Y, Mears CJ, Binns HJ, Taylor R (2009). "Chronic fatigue syndrome after infectious mononucleosis in adolescents". Pediatrics. 124 (1): 189–93. doi:10.1542/peds.2008-1879. PMC 2756827. PMID 19564299.
- ↑ Poynard T, Cacoub P, Ratziu V, Myers RP, Dezailles MH, Mercadier A; et al. (2002). "Fatigue in patients with chronic hepatitis C." J Viral Hepat. 9 (4): 295–303. doi:10.1046/j.1365-2893.2002.00364.x. PMID 12081607.
- ↑ "Retraction notice to "Differential impact of diabetes and hypertension in the brain: adverse effects in grey matter" [Neurobiol. Dis., 44 (2011) 161–173, http://dx.doi.org/10.1016/ j.nbd.2011.06.005]". Neurobiol Dis. 68: 229. 2014. doi:10.1016/j.nbd.2014.05.006. PMID 25077353. External link in
|title=
(help) - ↑ Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Schonberger LB, Straus SE; et al. (1988). "Chronic fatigue syndrome: a working case definition". Ann Intern Med. 108 (3): 387–9. doi:10.7326/0003-4819-108-3-387. PMID 2829679.
- ↑ Schmoldt A, Benthe HF, Haberland G, Kahn A, Vives JL, Bertrand O, Cottreau D, Marie J, Boivin P, Flohr H, Breull W, Smith RJ, Bryant RG, Koolman J, Karlson P (September 1975). "Digitoxin metabolism by rat liver microsomes". Biochem. Pharmacol. 24 (17): 1639–41. doi:10.1016/0009-8981(76)90051-6. PMID 10.
- ↑ "Reorganized text". JAMA Otolaryngol Head Neck Surg. 141 (5): 428. 2015. doi:10.1001/jamaoto.2015.0540. PMID 25996397.
- ↑ Green DJ, Muller S, Mallen CD, Hider SL (2015). "Fatigue as a precursor to polymyalgia rheumatica: an explorative retrospective cohort study". Scand J Rheumatol. 44 (3): 219–23. doi:10.3109/03009742.2014.959047. PMID 25366389.
- ↑ Visser MR, Smets EM (1998). "Fatigue, depression and quality of life in cancer patients: how are they related?". Support Care Cancer. 6 (2): 101–8. doi:10.1007/s005200050142. PMID 9540167.
- ↑ Fischler B, Cluydts R, De Gucht Y, Kaufman L, De Meirleir K (1997). "Generalized anxiety disorder in chronic fatigue syndrome". Acta Psychiatr Scand. 95 (5): 405–13. doi:10.1111/j.1600-0447.1997.tb09653.x. PMID 9197905.
- ↑ Manu P, Lane TJ, Matthews DA (1989). "Somatization disorder in patients with chronic fatigue". Psychosomatics. 30 (4): 388–95. doi:10.1016/S0033-3182(89)72244-1. PMID 2798731.
- ↑ Lindenfeld J, Albert NM, Boehmer JP, Collins SP, Ezekowitz JA, Givertz MM, Katz SD, Klapholz M, Moser DK, Rogers JG, Starling RC, Stevenson WG, Tang WH, Teerlink JR, Walsh MN (2010). "HFSA 2010 Comprehensive Heart Failure Practice Guideline". Journal of Cardiac Failure. 16 (6): e1–194. doi:10.1016/j.cardfail.2010.04.004. PMID 20610207. Retrieved 2013-04-29. Unknown parameter
|month=
ignored (help) - ↑ Gray A, Goodacre S, Newby DE, Masson M, Sampson F, Nicholl J (2008). "Noninvasive ventilation in acute cardiogenic pulmonary edema". N. Engl. J. Med. 359 (2): 142–51. doi:10.1056/NEJMoa0707992. PMID 18614781. Unknown parameter
|month=
ignored (help) - ↑ Peter JV, Moran JL, Phillips-Hughes J, Graham P, Bersten AD (2006). "Effect of non-invasive positive pressure ventilation (NIPPV) on mortality in patients with acute cardiogenic pulmonary oedema: a meta-analysis". Lancet. 367 (9517): 1155–63. doi:10.1016/S0140-6736(06)68506-1. PMID 16616558. Unknown parameter
|month=
ignored (help) - ↑ Weng CL; Zhao YT; Liu QH; et al. (2010). "Meta-analysis: Noninvasive ventilation in acute cardiogenic pulmonary edema". Ann. Intern. Med. 152 (9): 590–600. doi:10.1059/0003-4819-152-9-201005040-00009. PMID 20439577. Unknown parameter
|month=
ignored (help); Unknown parameter|author-separator=
ignored (help) - ↑ Smith SC, Feldman TE, Hirshfeld JW, Jacobs AK, Kern MJ, King SB et al. (2006) ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 113 (1):156-75. DOI:10.1161/CIRCULATIONAHA.105.170815 PMID: 16391169
- ↑ Rice KL, Dewan N, Bloomfield HE, Grill J, Schult TM, Nelson DB, Kumari S, Thomas M, Geist LJ, Beaner C, Caldwell M, Niewoehner DE (2010). "Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial". American Journal of Respiratory and Critical Care Medicine. 182 (7): 890–6. doi:10.1164/rccm.200910-1579OC. PMID 20075385. Retrieved 2012-03-20. Unknown parameter
|month=
ignored (help) - ↑ Dewan NA, Rice KL, Caldwell M, Hilleman DE (2011). "Economic evaluation of a disease management program for chronic obstructive pulmonary disease". Copd. 8 (3): 153–9. doi:10.3109/15412555.2011.560129. PMID 21513435. Retrieved 2012-03-20. Unknown parameter
|month=
ignored (help) - ↑ Chapman KR, Rennard SI, Dogra A, Owen R, Lassen C, Kramer B (2011). "Long-term safety and efficacy of indacaterol, a long-acting β₂-agonist, in subjects with COPD: a randomized, placebo-controlled study". Chest. 140 (1): 68–75. doi:10.1378/chest.10-1830. PMID 21349928. Retrieved 2012-03-19. Unknown parameter
|month=
ignored (help) - ↑ Barbé F, Durán-Cantolla J, Sánchez-de-la-Torre M; et al. (2012). "Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial". JAMA. 307 (20): 2161–8. doi:10.1001/jama.2012.4366. PMID 22618923. Unknown parameter
|month=
ignored (help) - ↑ Martínez-García M, Capote F, Campos-Rodríguez F, et al. Effect of CPAP on Blood Pressure in Patients With Obstructive Sleep Apnea and Resistant Hypertension: The HIPARCO Randomized Clinical Trial. JAMA. 2013;310(22):2407-2415. doi:10.1001/jama.2013.281250.
- ↑ Pedrosa RP, Drager LF, de Paula LK, Amaro AC, Bortolotto LA, Lorenzi-Filho G (2013). "Effects of OSA Treatment on BP in Patients With Resistant Hypertension: A Randomized Trial". Chest. 144 (5): 1487–94. doi:10.1378/chest.13-0085. PMID 23598607.
- ↑ Johansson K, Neovius M, Lagerros YT, Harlid R, Rössner S, Granath F; et al. (2009). "Effect of a very low energy diet on moderate and severe obstructive sleep apnoea in obese men: a randomised controlled trial". BMJ. 339: b4609. doi:10.1136/bmj.b4609. PMC 2788899. PMID 19959590.
- ↑ Hsu AA, Lo C (2003). "Continuous positive airway pressure therapy in sleep apnoea". Respirology. 8 (4): 447–54. doi:10.1046/j.1440-1843.2003.00494.x. PMID 14708553. Unknown parameter
|month=
ignored (help) - ↑ McDermott MT (2009). "In the clinic. Hypothyroidism". Ann. Intern. Med. 151 (11): ITC61. doi:10.7326/0003-4819-151-11-200912010-01006. PMID 19949140.
- ↑ Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE (2002). "Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)". J. Clin. Endocrinol. Metab. 87 (2): 489–99. doi:10.1210/jcem.87.2.8182. PMID 11836274.
- ↑ Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR (2007). "Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002)". Thyroid. 17 (12): 1211–23. doi:10.1089/thy.2006.0235. PMID 18177256.
- ↑ ADAMS DD (1965). "PATHOGENESIS OF THE HYPERTHYROIDISM OF GRAVES'S DISEASE". Br Med J. 1 (5441): 1015–9. PMC 2166943. PMID 14262190.
- ↑ Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M; et al. (2006). "ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society". Circulation. 114 (10): e385–484. doi:10.1161/CIRCULATIONAHA.106.178233. PMID 16935995.
- ↑ Corwin HL, Gettinger A, Pearl RG; et al. (2004). "The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States". Crit. Care Med. 32 (1): 39–52. doi:10.1097/01.CCM.0000104112.34142.79. PMID 14707558.
- ↑ Vincent JL, Baron JF, Reinhart K; et al. (2002). "Anemia and blood transfusion in critically ill patients". JAMA. 288 (12): 1499–507. PMID 12243637.
- ↑ MEDICAL SCIENCES S-nitrosohemoglobin deficiency: A mechanism for loss of physiological activity in banked blood James D. Reynolds*, Gregory S. Ahearn{dagger}, Michael Angelo{dagger}, Jian Zhang{dagger}, Fred Cobb{dagger},{ddagger}, and Jonathan S. Stamler Published online before print October 11, 2007 Proc. Natl. Acad. Sci. USA, 10.1073/pnas.0707958104 Accessed 10/15/07
- ↑ Candy B, Hotopf M. (2006). "Steroids for symptom control in infectious mononucleosis". Cochrane Database Sys Rev (4): CD004402. doi:10.1002/14651858.CD004402.pub2. PMID 16856045.
- ↑ Antibiotic Expert Group. Therapeutic guidelines: Antibiotic. 13th ed. North Melbourne: Therapeutic Guidelines; 2006.
- ↑ "Infectious Mononucleosis". WebMD. Jan 24, 2006. Retrieved 2006-07-10.
- ↑ Torre D, Tambini R (1999). "Acyclovir for treatment of infectious mononucleosis: a meta-analysis". Scand. J. Infect. Dis. 31 (6): 543–7. PMID 10680982.
- ↑ Balfour HH, Hokanson KM, Schacherer RM; et al. (2007). "A virologic pilot study of valacyclovir in infectious mononucleosis". J. Clin. Virol. 39 (1): 16–21. doi:10.1016/j.jcv.2007.02.002. PMID 17369082.
- ↑ Simon; et al. (2003). "The Effect of Valacyclovir and Prednisolone in Reducing Symptoms of EBV Illness In Children: A Double-Blind, Placebo-Controlled Study". International Pediatrics. 18 (3): 164–169. Unknown parameter
|month=
ignored (help) - ↑ Balfour HH, Hokanson KM, Schacherer RM; et al. (2007). "A virologic pilot study of valacyclovir in infectious mononucleosis". J. Clin. Virol. 39 (1): 16–21. doi:10.1016/j.jcv.2007.02.002. PMID 17369082.
- ↑ Vargas HE, Dodson FS, Rakela J (2002). "A concise update on the status of liver transplantation for hepatitis B virus: the challenges in 2002". Liver Transpl. 8 (1): 2–9. doi:10.1053/jlts.2002.29765. PMID 11799479.
- ↑ Omata M (1990). "Significance of extrahepatic replication of hepatitis B virus". Hepatology. 12 (2): 364–6. PMID 2202639.
- ↑ McGory RW, Ishitani MB, Oliveira WM, Stevenson WC, McCullough CS, Dickson RC; et al. (1996). "Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization". Transplantation. 61 (9): 1358–64. PMID 8629297.
- ↑ Marzano A, Gaia S, Ghisetti V, Carenzi S, Premoli A, Debernardi-Venon W; et al. (2005). "Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence". Liver Transpl. 11 (4): 402–9. doi:10.1002/lt.20402. PMID 15776431.
- ↑ Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA, O'Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM, Thomas JD (2014). "2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines". J. Am. Coll. Cardiol. 63 (22): 2438–88. doi:10.1016/j.jacc.2014.02.537. PMID 24603192.
- ↑ Plotnikoff GA, Quigley JM (2003). "Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain". Mayo Clin. Proc. 78 (12): 1463–70. PMID 14661675.
- ↑ Warner AE, Arnspiger SA (2008). "Diffuse musculoskeletal pain is not associated with low vitamin D levels or improved by treatment with vitamin D". J Clin Rheumatol. 14 (1): 12–6. doi:10.1097/RHU.0b013e31816356a9. PMID 18431091. Unknown parameter
|month=
ignored (help) - ↑ Arvold DS, Odean MJ, Dornfeld MP, Regal RR, Arvold JG, Karwoski GC; et al. (2009). "Correlation of symptoms with vitamin D deficiency and symptom response to cholecalciferol treatment: a randomized controlled trial". Endocr Pract. 15 (3): 203–12. PMID 19364687.
- ↑ 59.0 59.1 Kermani TA, Warrington KJ (2013). "Polymyalgia rheumatica". Lancet. 381 (9860): 63–72. doi:10.1016/S0140-6736(12)60680-1. PMID 23051717.
- ↑ Xu C, Peng H, Li R, Chai W, Li X, Fu J, Liu K, Yu B, Jia C, Chen J (October 2017). "Risk factors and clinical characteristics of deep knee infection in patients with intra-articular injections: A matched retrospective cohort analysis". Semin. Arthritis Rheum. doi:10.1016/j.semarthrit.2017.10.013. PMID 29129326.
- ↑ Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, Zwinderman AH, Ronday HK, Han KH, Westedt ML, Gerards AH, van Groenendael JH, Lems WF, van Krugten MV, Breedveld FC, Dijkmans BA (November 2005). "Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial". Arthritis Rheum. 52 (11): 3381–90. doi:10.1002/art.21405. PMID 16258899.
- ↑ van der Kooij SM, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Güler-Yüksel M, Zwinderman AH, Kerstens PJ, van der Lubbe PA, de Beus WM, Grillet BA, Ronday HK, Huizinga TW, Breedveld FC, Dijkmans BA, Allaart CF (June 2009). "Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis". Ann. Rheum. Dis. 68 (6): 914–21. doi:10.1136/ard.2008.092254. PMID 18662933.
- ↑ Wu AJ (November 2008). "Optimizing dry mouth treatment for individuals with Sjögren's syndrome". Rheum. Dis. Clin. North Am. 34 (4): 1001–10, x. doi:10.1016/j.rdc.2008.08.013. PMID 18984418.
- ↑ Thanou-Stavraki A, James JA (April 2008). "Primary Sjogren's syndrome: current and prospective therapies". Semin. Arthritis Rheum. 37 (5): 273–92. doi:10.1016/j.semarthrit.2007.06.002. PMID 17714766.
- ↑ Ramos-Casals M, Brito-Zerón P, Sisó-Almirall A, Bosch X, Tzioufas AG (May 2012). "Topical and systemic medications for the treatment of primary Sjögren's syndrome". Nat Rev Rheumatol. 8 (7): 399–411. doi:10.1038/nrrheum.2012.53. PMID 22549247.
- ↑ Furness S, Worthington HV, Bryan G, Birchenough S, McMillan R (December 2011). "Interventions for the management of dry mouth: topical therapies". Cochrane Database Syst Rev (12): CD008934. doi:10.1002/14651858.CD008934.pub2. PMID 22161442.
- ↑ Diagnostic and statistical manual of mental disorders : DSM-5. Washington, D.C: American Psychiatric Association. 2013. ISBN 0890425558.